A case for ribavirin to treat chronic hepatitis E.


n engl j med 370;12 nejm.org march 20, 2014 1162 2. Mössner E, Brünker P, Moser S, et al. Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell-mediated B-cell cytotoxicity. Blood 2010;115: 4393-402. 3. Honeychurch J, Alduaij W, Azizyan M, et al… (More)
DOI: 10.1056/NEJMe1401440


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics